First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
about
Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase®.The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis.Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI.Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011The value of patient reporting to the pharmacovigilance system: a systematic review.ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.Comment on "Patient Reporting in the EU: Analysis of EudraVigilance Data".Pharmacovigilance: empowering healthcare professionals and patients.Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial.Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database
P2860
Q33425628-30C8FDAC-BFF8-47BB-BE0F-5F69C3706404Q33845548-70D5E56D-34E6-43E4-9066-C65B0D6FBE48Q34033938-AAF64910-B399-4D0C-BE4F-10712447A14FQ34771486-3287F733-BA3D-4864-9C5F-13A7D086DA69Q36112324-5BE412B1-26FB-42FD-BC94-3FFCA5EEE01DQ38334927-390FBB61-FAD7-4644-B4EF-8AE5C4851B17Q39229385-C9168AD4-5701-4F1F-9305-1ABBF64DF8CAQ40690033-7793D151-A829-410E-B4CC-FEA597D7CF07Q46378567-CE882CFE-E810-4D3A-B924-A479B3A5CFF2Q47732295-65D1A853-BF23-48D3-9F48-1455B069F469Q52664035-E9B2B315-7ECE-437C-A7EE-A8E9AB02791BQ52664572-A029E656-0931-445A-A7C2-8B6A6C51BDBF
P2860
First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
First French experience of ADR ...... and healthcare professionals.
@ast
First French experience of ADR ...... and healthcare professionals.
@en
type
label
First French experience of ADR ...... and healthcare professionals.
@ast
First French experience of ADR ...... and healthcare professionals.
@en
prefLabel
First French experience of ADR ...... and healthcare professionals.
@ast
First French experience of ADR ...... and healthcare professionals.
@en
P2093
P2860
P50
P356
P1433
P1476
First French experience of ADR ...... and healthcare professionals.
@en
P2093
Alexis Jacquet
Angeline Faucher
Anne Castot
Carmen Kreft-Jais
French Network of Pharmacovigilance Centres
Geneviève Durrieu
Laure Pourcel
Marie Christine Perault-Pochat
Shéhérazade Ouaret
P2860
P2888
P304
P356
10.1007/BF03261980
P577
2012-10-01T00:00:00Z
P5875
P6179
1011659675